
Science in Space Matters w/ Ken Savin #58
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Acerca de esta escucha
In This Episode
Join David Goldsmith as he welcomes Ken Sabin, Chief Science Officer at Redwire, to explore the transformative potential of science in space. With over 20 years in the pharmaceutical industry, Ken shares his insights on how space exploration can lead to groundbreaking advancements in medicine and technology. Key moments include discussions on the unique benefits of microgravity for crystal growth and tissue engineering, as well as the importance of collaboration between private companies and governmental agencies. The conversation takes unexpected turns as they delve into the challenges faced by organizations like Astrobotic and the broader implications for humanity's future in space.
Ken emphasizes that the ultimate goal of space science is to improve life on Earth through innovative solutions derived from extraterrestrial research. As they discuss the evolution of space exploration, listeners gain a deeper understanding of how these efforts can bridge gaps between technology and human welfare.
Episode Outlines
- Introduction to Ken Sabin and his role at Redwire
- The definition and significance of science in space
- Unique advantages of conducting experiments in microgravity
- The role of collaboration between private companies and NASA
- Challenges faced by organizations like Astrobotic
- The impact of failures on future space missions
- Innovations in tissue engineering and pharmaceuticals from space research
- The importance of inclusivity in global space initiatives
- Long-term goals for humanity's presence beyond Earth
- Conclusion: Optimism for the future of science in space
Biography of the Guest
Ken Sabin is the Chief Science Officer at Redwire, where he leads innovative projects focused on advancing science and technology in space. With a PhD in chemistry and over two decades of experience in the pharmaceutical industry, Ken has worked with prominent firms such as Eli Lilly. His current projects include protein crystal growth and biofabrication facilities aboard the International Space Station. Ken is passionate about leveraging space research to create solutions that benefit humanity on Earth, making him a vital voice in discussions about the future of science and exploration. The themes in today’s episode are just the beginning. Dive deeper into innovation, interconnected thinking, and paradigm-shifting ideas at www.projectmoonhut.org—where the future is being built.